MAPS Webinar 9/15/23 Listen tot he full webianr >> Clinical research is typically costly for sponsors and burdensome for providers and patients. New methods and approaches, such as integrated evidence generation using real-world data networks and automated study platforms, are accelerating the path from start-up to read out.
Listen to the full podcast >> Healtheconmoncs.com July 26, 2023 On this episode of tHEORetically speaking features Gary Curhan, Chief Medical Officer and Jessica Paulus, Vice President of Research at OM1, as they answer questions on Leveraging Real-World Data for Precision Obesity Treatment.
Read the full press release >> BOSTON–(BUSINESS WIRE)–OM1, the leading real-world data and technology company focused on chronic conditions, today announced the launch of its Parkinson’s Disease (PD) premium dataset and the enhancement of its Mental Health & Neuroscience Real-World Data Network. The dataset includes more than 7,000 patients prospectively followed by neurologists in hundreds of clinics across[…]
PM360 July 13, 2023 Read the full article>> Reasons for Discontinuation (RfD) Analytics Report An estimated 50% of patients with a prescription for a chronic condition stop taking it within the first year, leading to worse outcomes and nearly $250 billion lost revenue annually for the pharmaceutical industry. To combat this, OM1 launched its Reasons for Discontinuation[…]
Patti Peeples June 22, 2023 The Evidence Base Watch the full interview >>
